Undescended testicle, also known as cryptorchidism, is a condition where one or both testicles remain undescended inside the abdomen or inguinal canal. Undescended testicles require early treatment as it increases the risk of infertility and testicular cancer later in life. Treatments for undescended testicles include medications, surgery, and hormone therapy based on the patient's age and condition. The global undescended testicle treatment market offers minimally invasive and non-invasive treatment options with improved success rates and reduced postoperative complications. The market comprises drugs for hormone therapy, surgical instruments for orchiopexy surgery, and medical devices for non-surgical therapy.
The undescended testicle market size is expected to reach US$ 7.38 billion by 2030, from US$ 4.51 billion in 2023, at a CAGR of 7.3% during the forecast period.
Key Takeaways
Key players operating in the global undescended testicle treatment market are Eli Lilly and Company, Bayer AG, Endo Pharmaceuticals, Actavis Pharma, and Debiopharm Group.
The rising awareness and early diagnosis of undescended testicle condition is a major factor driving the Global Undescended Testicle Market growth. Various initiatives undertaken by healthcare organizations and government bodies to spread awareness regarding the lifelong implications of untreated cryptorchidism are helping more patients seek timely treatment.
Technological advancements are bringing new minimally invasive and non-surgical treatment options for undescended testicles. Developments such as intratesticular injection for medication therapy and innovative testicular implants are resulting in better treatment outcomes and success rates. This is encouraging wider adoption of advanced therapeutic approaches.
Market Trends
Non-surgical therapies: Advancements in non-invasive hormone therapies and intratesticular injections are gaining popularity as they avoid surgery-related risks and complications. These options are set to expand due to their effectiveness as primary as well as adjuvant treatments.
Fertility preservation: With growing concern about fertility preservation, testicular tissue cryopreservation prior to therapy is emerging as a trend to safeguard future reproductive potential in case of postoperative complications or adverse effects of hormonal medications.
Market Opportunities
Developing economies: Developing countries in Asia Pacific and Latin America present lucrative opportunities for market players due to growing medical infrastructure, rising healthcare spending, and increasing awareness levels in these regions.
Combination therapies: Combining hormone medications with non-invasive local therapies and tissue-preserving surgical techniques presents a major opportunity to optimize outcomes with multimodal protocols.
Impact of COVID-19 on Global Undescended Testicle Market Growth:
The COVID-19 pandemic has impacted the global undescended testicle market growth in both short term and long term. In the short run, there has been a decline in new referrals and diagnosis of undescended testis cases. Several non-emergency surgeries were postponed to prioritize the treatment of COVID-19 patients. This led to delay in undescended testicle operations and caused backlog. However, physicians continued remote consultations and provided advice over virtual platforms to support affected families.
In the post-COVID era, the market is expected to recover gradually as elective surgeries resume. The demand for undescended testicle treatments may rise to clear the pending cases. Additionally, improved access to telehealth can aid steady diagnosis. Nevertheless, the threat of subsequent waves remains a challenge. Healthcare systems need to strengthen their capabilities to effectively handle both COVID-19 and non-COVID healthcare requirements simultaneously. Close monitoring of the virus situation and ensuring safety protocols in clinical settings will be crucial for market growth.
Geographical Regions with High Market Concentration:
North America dominates the global undescended testicle market in terms of value. This is attributed to rising healthcare expenditure, technological advancement in surgical procedures, and growing public awareness about testicular health issues. The availability of skilled pediatric surgeons and well-established reimbursement policies support market growth in the region. Going forward, Asia Pacific is projected to be the fastest growing regional market due to increasing medical tourism, presence of low-cost treatment options and rapid economic development of countries like China and India. Greater investment in pediatric healthcare infrastructure can further boost the APAC market.
Fastest Growing Geographical Region:
Asia Pacific is poised to register the highest CAGR during the forecast period in the global undescended testicle market. This is driven by rapidly growing patient population, rising disposable income, expanding medical insurance coverage and improving access to advanced healthcare facilities. Moreover, investments by public and private players in pediatric specialties encourage international patients to travel to Asia Pacific countries for affordable medical care. Initiatives by governments and non-profit organizations to spread awareness about cryptorchidism can increase the treatment seeking rate in emerging nations. All these factors will fuel the Asia Pacific market growth at a faster pace.
Gain further insights directly from the source: The Global Undescended Testicle Market is set to surge by increased Prevalence of Cryptorchidism
Gain further insights directly from the source: Global Undescended Testicle Market to Witness Significant Growth
Gain further insights directly from the source: Technological Breakthroughs in the Global Undescended Testicle Treatment
Gain further insights directly from the source: Global Undescended Testicle Market is Anticipated to Witness High Growth Owing to Increasing Awareness about Testicular Cancer Risks
Author Bio:
Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemical and materials, defense and aerospace, consumer goods, etc. (https://www.linkedin.com/in/money-singh-590844163)